Related Experiment Video
Updated: Aug 6, 2026

Histological Quantification of Chronic Myocardial Infarct in Rats
Published on: December 11, 2016
Relationship between corrected TIMI frame counts at three weeks and late survival after myocardial infarction
J K French1, T A Hyde, I T Straznicky
1Cardiology Department, Green Lane Hospital, Auckland, New Zealand. johnf@ahsl.co.nz
Insights
The corrected Thrombolysis in Myocardial Infarction (CTFC) predicts five-year survival after myocardial infarction. While CTFC offers prognostic value, it did not prove superior to TIMI flow grade for long-term outcomes.
Area of Science:
- Cardiology
- Medical Imaging
- Clinical Outcomes Research
Background:
- Thrombolysis in Myocardial Infarction (TIMI) flow grades predict survival post-myocardial infarction (MI).
- Corrected TIMI frame count (CTFC) offers more reproducible infarct-related artery blood flow assessment than TIMI flow grade.
- Previous studies linked CTFC to 30-day outcomes, but its correlation with late survival remained unestablished.
Purpose of the Study:
- To evaluate the corrected Thrombolysis in Myocardial Infarction (CTFC) as a predictor of late survival following myocardial infarction.
- To determine if CTFC provides additional prognostic information beyond traditional TIMI flow grades for long-term cardiac outcomes.
Main Methods:
- 1,001 patients with acute myocardial infarction underwent angiography approximately three weeks post-event.
- Infarct artery blood flow was assessed using both CTFC and TIMI flow grade, blinded to clinical outcomes.
- Late cardiac mortality and survival were tracked in 97.5% of the patient cohort.
Main Results:
- The mean CTFC was 40 ± 29 in patent infarct arteries.
- Both CTFC and TIMI flow grade were significant univariate predictors of five-year survival (p < 0.001).
- Multivariate analysis identified ejection fraction, end-systolic volume index, exercise duration, age, diabetes, and CTFC/TIMI flow grade as predictors of five-year survival.
Conclusions:
- CTFC independently predicted five-year survival after myocardial infarction, but not ten-year survival.
- CTFC provided supplementary prognostic information within existing TIMI flow grades.
- The study did not demonstrate the superiority of CTFC over TIMI flow grade for predicting long-term survival.
Objectives:
To evaluate the corrected Thrombolysis in Myocardial Infarction (TIMI) frame count (CTFC) as a predictor of late survival after myocardial infarction.
Background:
Thrombolysis in Myocardial Infarction flow grades predict late survival after myocardial infarction. The CTFC provides a more reproducible measurement of infarct-related artery blood flow than the TIMI flow grade, and has been linked to 30-day outcomes, but it has not yet been established how the CTFC correlates with late survival.
Methods:
Of 1,001 patients with acute myocardial infarction presenting within 4 h of symptom onset, 882 underwent angiography at approximately three weeks. Infarct artery flow was assessed, blinded to clinical outcomes, according to the CTFC and TIMI flow grade. Late cardiac mortality and survival were determined in 97.5% of patients.
Results:
The mean CTFC was 40 +/- 29 in 644 patent infarct arteries (median, 34 [interquartile range, 24 to 47]). The CTFC, assessed as a continuous univariate variable, was found to be a predictor of five-year survival, as was the TIMI flow grade (both p < 0.001). On multivariate analysis, factors associated with five-year survival included the ejection fraction or end-systolic volume index (both p < 0.001); exercise duration (p = 0.005), age (p = 0.008), diabetes (p = 0.02) and CTFC (p = 0.02) or TIMI flow (p = 0.02). The same factors, except for the CTFC and TIMI flow grade, were predictors of 10-year survival.
Conclusions:
The CTFC three weeks after myocardial infarction was an independent predictor of five-year survival, but not 10-year survival. Although the CTFC provided additional prognostic information within TIMI flow grades, its superiority was not demonstrated.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies

